Head & neck

publication venue for

A Rare Case of Ewing Sarcoma of the Left Ethmoid Sinus With Orbital Extension. 2024
The value of ⁶⁸ Gallium-DOTATATE PET/CT in sinonasal neuroendocrine tumor management: A case series. 2021
Biochemical and clinical responses after treatment of a catecholamine-secreting glomus jugulare tumor with gamma knife radiosurgery. 2010
Evaluating Depth of Invasion as a Continuous Prognostic Factor in Oral Squamous Cell Carcinoma. 2024
Management of laryngeal chondroradionecrosis: A single-center experience. 2024
Financial (dis)incentives to surgical management of head and neck cancer care. 2024
Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer.. 45. 2023
Identification of occult metastatic disease via lymphoscintigraphy-guided neck dissection in N0 oral squamous cell carcinoma. 2022
Palliative care in metastatic head and neck cancer.. 43. 2021
Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.. 43. 2021
Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.. 43. 2020
Role of intraoperative recurrent laryngeal nerve monitoring for pediatric thyroid surgery: Comparative analysis.. 43. 2020
Nodal disease burden and outcome of medullary thyroid carcinoma.. 43. 2020
Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study.. 43. 2020
Prediction of distant metastases in patients with squamous cell carcinoma of head and neck using DWI and DCE-MRI.. 42. 2020
Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.. 42. 2020
Squamous cell carcinoma of the oral tongue: Distinct epidemiological profile disease.. 42. 2020
Intraoperative nerve monitoring is used routinely by a significant majority of head and neck surgeons in thyroid surgery and impacts on extent of surgery-Survey of the American Head and Neck Society.. 42. 2020
MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality.. 42. 2020
Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.. 42. 2020
Pilot study for a novel and personalized voice restoration device for patients with laryngectomy.. 42. 2019
The risk of second primary tumors in head and neck cancer: A systematic review.. 42. 2019
Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.. 42. 2019
Salvage surgery for recurrent larynx cancer.. 41. 2019
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach.. 41. 2019
Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy-free survival in those refusing surgery.. 41. 2019
Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?. 41. 2019
Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma.. 40. 2018
AHNS Series: Do you know your guidelines? AHNS Endocrine Section Consensus Statement: State-of-the-art thyroid surgical recommendations in the era of noninvasive follicular thyroid neoplasm with papillary-like nuclear features.. 40. 2018
Patterns of recurrence in oral tongue cancer with perineural invasion.. 40. 2018
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.. 40. 2017
Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study.. 39. 2017
Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.. 38. 2016
Role of perioperative antibiotic treatment in parotid gland surgery.. 38 Suppl 1. 2015
Impact of elective neck dissection on the outcome of oral squamous cell carcinomas arising in the maxillary alveolus and hard palate.. 38 Suppl 1. 2015
Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.. 38 Suppl 1. 2015
Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma.. 38 Suppl 1. 2015
Salvage surgery for locally recurrent oropharyngeal cancer.. 38 Suppl 1. 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.. 38 Suppl 1. 2015
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.. 38 Suppl 1. 2015
Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system.. 38. 2015
Silk-elastin-like protein polymer matrix for intraoperative delivery of an oncolytic vaccinia virus.. 38. 2015
Incidental thyroid nodules in patients with primary hyperparathyroidism.. 36. 2014
Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers.. 37. 2014
Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study.. 37. 2014
International collaborative validation of intraneural invasion as a prognostic marker in adenoid cystic carcinoma of the head and neck.. 37. 2014
Accuracy of administrative and clinical registry data in reporting postoperative complications after surgery for oral cavity squamous cell carcinoma.. 37. 2014
Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation.. 37. 2014
Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study.. 36. 2013
Cancer of the head and neck region in solid organ transplant recipients.. 36. 2013
Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know.. 35. 2012
Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation.. 35. 2012
Nomogram for selecting thyroid nodules for ultrasound-guided fine-needle aspiration biopsy based on a quantification of risk of malignancy.. 35. 2012
Preliminary evaluation of the reliability and validity of the Shame and Stigma Scale in head and neck cancer.. 35. 2012
Surgical management of squamous cell carcinoma of the soft palate: factors predictive of outcome.. 34. 2011
Murine model of neuromuscular electrical stimulation on squamous cell carcinoma: potential implications for dysphagia therapy.. 34. 2011
Improvement in survival during the past 4 decades among patients with anterior skull base cancer.. 34. 2011
Predictors of survival and recurrence after temporal bone resection for cancer.. 34. 2011
Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma.. 34. 2011
Role of parathyroid hormone monitoring during parathyroidectomy.. 33. 2011
Minimally invasive video-assisted thyroidectomy 2.0: expanded indications in a tertiary care cancer center.. 33. 2010
Transoral robotic surgery and human papillomavirus status: Oncologic results.. 33. 2010
Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma.. 32. 2010
Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma.. 33. 2010
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer.. 33. 2010
Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome.. 33. 2010
Comparison of pharyngocutaneous fistula between patients followed by primary laryngopharyngectomy and salvage laryngopharyngectomy for advanced hypopharyngeal cancer.. 32. 2010
High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus.. 33. 2010
Postoperative hypocalcemia--the difference a definition makes.. 32. 2010
Adopting the operating microscope in thyroid surgery: safety, efficiency, and ergonomics.. 32. 2010
Late esophageal toxicity after radiation therapy for head and neck cancer.. 32. 2010
Elevated parathyroid hormone levels after parathyroidectomy for primary hyperparathyroidism.. 31. 2009
Predictors of outcome for advanced-stage supraglottic laryngeal cancer.. 31. 2009
Analysis of postoperative complications of open partial laryngectomy.. 31. 2009
Outcome of craniofacial surgery in children and adolescents with malignant tumors involving the skull base: an international collaborative study.. 31. 2009
Comparison of perioperative management and outcome of parathyroidectomy between older and younger patients.. 30. 2008
Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma.. 30. 2008
Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma.. 30. 2008
Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.. 30. 2008
PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck.. 30. 2008
Vessel-depleted neck: techniques for achieving microvascular reconstruction.. 30. 2008
Outcome of craniofacial resection in patients 70 years of age and older.. 29. 2007
Internal mammary artery perforator (IMAP) flap for tracheostoma reconstruction.. 28. 2006
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx.. 27. 2005
Prevalence of lymph nodes in the apex of level V: a plea against the necessity to dissect the apex of level V in mucosal head and neck cancer.. 27. 2005
C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck.. 27. 2005
Craniofacial resection for malignant paranasal sinus tumors: Report of an International Collaborative Study.. 27. 2005
Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study.. 27. 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.. 27. 2005
Efficacy of speech aid prostheses for acquired defects of the soft palate and velopharyngeal inadequacy--clinical assessments and cephalometric analysis: a Memorial Sloan-Kettering Study.. 27. 2005
Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.. 26. 2004
Primary mucosal desmoplastic melanoma of the head and neck.. 26. 2004
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment.. 26. 2004
Cancer of the oral cavity: a comparison between institutions in a developing and a developed nation.. 26. 2004
Genetic abnormalities associated with nodal metastasis in head and neck cancer.. 26. 2004
Hard palate resection, microvascular reconstruction, and prosthetic restoration: a 14-year retrospective analysis.. 25. 2003
Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience.. 25. 2003
Anterior cranial base reconstruction using free tissue transfer: changing trends.. 25. 2003
Prediction of survival in patients with head and neck cancer using the histoculture drug response assay.. 24. 2002
Primary mucosal malignant melanoma of the head and neck.. 24. 2002
Functional status after primary surgical therapy for squamous cell carcinoma of the base of the tongue.. 24. 2002
Parathyroid cytology: avoiding diagnostic pitfalls.. 24. 2002
Evolution of precancerous laryngeal lesions: A clinicopathologic study with long-term follow-up on 259 patients. 23. 2001
Evolution of precancerous laryngeal lesions: a clinicopathologic study with long-term follow-up on 259 patients.. 23. 2001
Desmoid tumors of the head and neck--a clinical study of a rare entity.. 22. 2000
Parathyroid biopsy to facilitate the preservation of functional parathyroid tissue during thyroidectomy.. 21. 1999
Competitive PCR to detect eIF4E gene amplification in head and neck cancer.. 21. 1999
Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue.. 20. 1998
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck.. 20. 1998
Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis.. 20. 1998
Patterns of failure in differentiated carcinoma of the thyroid based on risk groups.. 20. 1998
Baseline and post-treatment assessment of the general health status of head and neck cancer patients compared with United States population norms.. 19. 1997
Resection and immediate microvascular reconstruction in the management of osteoradionecrosis of the mandible.. 19. 1997
Maxillectomy and its classification.. 19. 1997
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue.. 19. 1997
Posterior pharyngeal carcinoma resection with larynx preservation and radial forearm free flap reconstruction: a preliminary report.. 18. 1996
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.. 18. 1996
Quality of life of maxillectomy patients using an obturator prosthesis.. 18. 1996
Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.. 18. 1996
Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: epsilon PKC, a novel prognostic factor for relapse and survival.. 17. 1995
Folded free radial forearm flap for reconstruction of full-thickness defects of the cheek.. 17. 1995
Supraomohyoid neck dissection as a staging procedure for squamous cell carcinomas of the oral cavity and oropharynx.. 17. 1995
Complications of craniofacial resection for tumors involving the anterior skull base.. 16. 1994
Soft tissue coverage of mandibular reconstruction plates.. 16. 1994
Innervation of the trapezius muscle by the intra-operative measurement of motor action potentials.. 15. 1993
Carcinoma of the uvula and midline soft palate: indication for neck treatment.. 14. 1992
Preoperative evaluation of the mandible in patients with carcinoma of the floor of mouth.. 13. 1991
Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome.. 12. 1990
Conservation surgery for radiation-failure carcinoma of the glottic larynx.. 12. 1990
Gadolinium-enhanced MRI of tumors of the head and neck.. 12. 1990
Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx.. 12. 1990
Operative treatment of substernal goiters.. 11. 1989
Recent historic perspective on modified neck dissection.. 41. 2019
An enhanced TNM. 2002
Workshop report: organ preservation strategies in advanced head and neck cancer--current status and future directions. 1999
Systematic and other reviews: Criteria and complexities.. 43. 2021
Transoral parathyroidectomy-Why make a simple operation complicated? A surgical fantasy.. 41. 2019
The value of resident presentations at scientific meetings.. 35. 2012
Proposal for a rational classification of neck dissections.. 33. 2010
Contemporary management of primary parapharyngeal space tumors. 2018
Prognosis of subglottic carcinoma: Is it really worse? 2018
Image-guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications. 2018
Prognostic value of lymph node ratio in head and neck squamous cell carcinoma. 2018
Cervical lymph node metastases from remote primary tumor sites. 2015
Optimizing perioperative management of geriatric patients with head and neck cancer. 2013
Decision making in the management of recurrent head and neck cancer. 2013
Level V in therapeutic neck dissections for papillary thyroid carcinoma. 2012
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. 2011
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. 2011
Parathyroid carcinoma: a review. 2011
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. 2010
Contemporary management of sinonasal cancer. 2010
Retropharyngeal lymph node metastases in head and neck malignancies. 2010
Paratracheal lymph node dissection in cancer of the larynx, hypopharynx, and cervical esophagus: the need for guidelines. 2010
Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. 2010
Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma. 2006
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? 2006
New molecular diagnostic methods in head and neck cancer. 2005
Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. 2002
AHNS Series--Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors. 2016

VIVO Weill Cornell Medical College

Head & neck Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)